BlackRock’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.65M Sell
1,861,591
-118,960
-6% -$279K ﹤0.01% 3947
2025
Q4
$5.37M Buy
1,980,551
+8,862
+0.4% +$29.1K ﹤0.01% 3813
2025
Q3
$8.34M Buy
1,971,689
+243,477
+14% +$1.07M ﹤0.01% 3544
2025
Q2
$8.61M Sell
1,728,212
-40,494
-2% -$176K ﹤0.01% 3483
2025
Q1
$7.8M Buy
1,768,706
+41,625
+2% +$195K ﹤0.01% 3446
2024
Q4
$8.03M Sell
1,727,081
-12,622
-0.7% -$69.4K ﹤0.01% 3535
2024
Q3
$12.1M Buy
1,739,703
+1,350
+0.1% +$10.6K ﹤0.01% 3312
2024
Q2
$13.6M Buy
1,738,353
+46,995
+3% +$348K ﹤0.01% 3208
2024
Q1
$12M Sell
1,691,358
-156,443
-8% -$1.03M ﹤0.01% 3257
2023
Q4
$12.4M Sell
1,847,801
-2,963
-0.2% -$16.7K ﹤0.01% 3279
2023
Q3
$10.4M Sell
1,850,764
-193,196
-9% -$1.29M ﹤0.01% 3305
2023
Q2
$11.3M Sell
2,043,960
-99,517
-5% -$536K ﹤0.01% 3365
2023
Q1
$13.4M Sell
2,143,477
-44,612
-2% -$249K ﹤0.01% 3167
2022
Q4
$10.2M Buy
2,188,089
+387,738
+22% +$1.91M ﹤0.01% 3387
2022
Q3
$8.41M Buy
1,800,351
+248,593
+16% +$1.57M ﹤0.01% 3515
2022
Q2
$9.19M Buy
1,551,758
+441,602
+40% +$4.92M ﹤0.01% 3551
2022
Q1
$21.5M Buy
1,110,156
+60,979
+6% +$1.4M ﹤0.01% 3126
2021
Q4
$34.3M Sell
1,049,177
-11,682
-1% -$470K ﹤0.01% 2935
2021
Q3
$43.5M Sell
1,060,859
-139,805
-12% -$5.07M ﹤0.01% 2759
2021
Q2
$43.2M Sell
1,200,664
-532,143
-31% -$19.6M ﹤0.01% 2796
2021
Q1
$67.6M Buy
1,732,807
+163,273
+10% +$7.34M ﹤0.01% 2420
2020
Q4
$63.3M Buy
1,569,534
+455,576
+41% +$20.9M ﹤0.01% 2340
2020
Q3
$61.9M Buy
+1,113,958
New +$59M ﹤0.01% 2167

Other funds holding GDRX

BlackRock's GDRX Position: Q1 2026 in Review

BlackRock reduced its GoodRx Holdings (GDRX) stake by 6% in Q1 2026, selling an estimated $279K and leaving 1,861,591 shares worth $3.65M. The position accounts for ﹤0.01% of the portfolio, ranked #3947.

BlackRock first reported a position in GDRX in Q3 2020 and has held it in 23 quarters since. The position peaked at $67.6M in Q1 2021. 174 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.

  • BlackRock held 1,861,591 shares of GoodRx Holdings worth $3.65M as of Q1 2026.
  • BlackRock sold 118,960 GoodRx Holdings shares in Q1 2026, an estimated $279K.
  • GoodRx Holdings made up ﹤0.01% of BlackRock's portfolio in Q1 2026, its #3947 holding.
  • BlackRock first reported a position in GoodRx Holdings in Q3 2020 and has held it in 23 quarters since.
  • BlackRock's GoodRx Holdings position peaked at $67.6M in Q1 2021.
  • 174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.